Literature DB >> 11883083

Streamlined large-scale production of recombinant adeno-associated virus (rAAV) vectors.

Mark Potter1, Kye Chesnut, Nicholas Muzyczka, Terry Flotte, Sergei Zolotukhin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11883083     DOI： 10.1016/s0076-6879(02)46069-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  11 in total

1.  Preclinical toxicology and biodistribution studies of recombinant adeno-associated virus 1 human acid α-glucosidase.

Authors:  Thomas J Conlon; Kirsten Erger; Stacy Porvasnik; Travis Cossette; Cheryl Roberts; Lynn Combee; Saleem Islam; Jeffry Kelley; Denise Cloutier; Nathalie Clément; Corinne R Abernathy; Barry J Byrne
Journal:  Hum Gene Ther Clin Dev       Date:  2013-09       Impact factor: 5.032

2.  Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system.

Authors:  Erik Kohlbrenner; George Aslanidi; Kevin Nash; Stanislav Shklyaev; Martha Campbell-Thompson; Barry J Byrne; Richard O Snyder; Nicholas Muzyczka; Kenneth H Warrington; Sergei Zolotukhin
Journal:  Mol Ther       Date:  2005-10-06       Impact factor: 11.454

3.  A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini.

Authors:  Stephanie Kronenberg; Bettina Böttcher; Claus W von der Lieth; Svenja Bleker; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2.

Authors:  Wu Xiao; Kenneth H Warrington; Patrick Hearing; Jeffrey Hughes; Nicholas Muzyczka
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus.

Authors:  Florian Sonntag; Svenja Bleker; Barbara Leuchs; Roger Fischer; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

6.  Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale.

Authors:  Martin Lock; Mauricio Alvira; Luk H Vandenberghe; Arabinda Samanta; Jaan Toelen; Zeger Debyser; James M Wilson
Journal:  Hum Gene Ther       Date:  2010-10       Impact factor: 5.695

Review 7.  Crossing the blood-brain barrier with AAV vectors.

Authors:  Dan Liu; Mingyang Zhu; Yuqian Zhang; Yong Diao
Journal:  Metab Brain Dis       Date:  2020-11-17       Impact factor: 3.584

8.  SCHEMA computational design of virus capsid chimeras: calibrating how genome packaging, protection, and transduction correlate with calculated structural disruption.

Authors:  Michelle L Ho; Benjamin A Adler; Michael L Torre; Jonathan J Silberg; Junghae Suh
Journal:  ACS Synth Biol       Date:  2013-08-22       Impact factor: 5.110

9.  Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria.

Authors:  Alexandre Rebuffat; Cary O Harding; Zhaobing Ding; Beat Thöny
Journal:  Hum Gene Ther       Date:  2010-04       Impact factor: 5.695

Review 10.  Manufacturing of recombinant adeno-associated viral vectors for clinical trials.

Authors:  Nathalie Clément; Joshua C Grieger
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-16       Impact factor: 6.698
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.